Bio-Rad Laboratories, Inc.
Price Action
Technical Summary
CONSOLIDATINGBio-Rad Laboratories, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 48), showing significant lag compared to the market leaders. Earnings contraction of 10% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $290.26 | +0.77% | ABOVE |
| 50 SMA | $283.12 | +3.31% | ABOVE |
| 100 SMA | $280.06 | +4.44% | ABOVE |
| 150 SMA | $289.64 | +0.99% | ABOVE |
| 200 SMA | $294.05 | -0.53% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BIO in an uptrend right now?
BIO has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is BIO overbought or oversold?
BIO's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is BIO outperforming the market?
BIO has a Relative Strength (RS) Rating of 48 out of 99. BIO is currently lagging the broader market.
Where is BIO in its 52-week range?
BIO is trading at $292.50, which is 85% of its 52-week high ($343.12) and 52% above its 52-week low ($236.73).
How volatile is BIO?
BIO has a Beta of 0.72 and 52-week volatility of 42%. It's less volatile than the S&P 500 - generally more stable.